JP2021532095A5 - - Google Patents

Info

Publication number
JP2021532095A5
JP2021532095A5 JP2021502870A JP2021502870A JP2021532095A5 JP 2021532095 A5 JP2021532095 A5 JP 2021532095A5 JP 2021502870 A JP2021502870 A JP 2021502870A JP 2021502870 A JP2021502870 A JP 2021502870A JP 2021532095 A5 JP2021532095 A5 JP 2021532095A5
Authority
JP
Japan
Prior art keywords
stem cells
human
pharmaceutical composition
mitochondrial
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021502870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021532095A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2019/050824 external-priority patent/WO2020021537A1/en
Publication of JP2021532095A publication Critical patent/JP2021532095A/ja
Publication of JP2021532095A5 publication Critical patent/JP2021532095A5/ja
Pending legal-status Critical Current

Links

JP2021502870A 2018-07-22 2019-07-22 肝臓疾患のミトコンドリア増強療法 Pending JP2021532095A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862701783P 2018-07-22 2018-07-22
US62/701,783 2018-07-22
US201862753939P 2018-11-01 2018-11-01
US62/753,939 2018-11-01
PCT/IL2019/050824 WO2020021537A1 (en) 2018-07-22 2019-07-22 Mitochondrial augmentation therapy of liver diseases

Publications (2)

Publication Number Publication Date
JP2021532095A JP2021532095A (ja) 2021-11-25
JP2021532095A5 true JP2021532095A5 (cg-RX-API-DMAC10.html) 2022-07-27

Family

ID=69181382

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021502870A Pending JP2021532095A (ja) 2018-07-22 2019-07-22 肝臓疾患のミトコンドリア増強療法

Country Status (4)

Country Link
US (1) US20210252075A1 (cg-RX-API-DMAC10.html)
EP (1) EP3823643A4 (cg-RX-API-DMAC10.html)
JP (1) JP2021532095A (cg-RX-API-DMAC10.html)
WO (1) WO2020021537A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL282198B2 (en) 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
US12329781B2 (en) 2018-07-22 2025-06-17 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of renal diseases
EP3823644A4 (en) 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
JP7524157B2 (ja) 2018-07-22 2024-07-29 ミノヴィア セラピューティクス リミテッド 脳疾患のミトコンドリア増強療法
WO2020021539A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases
US12502408B2 (en) 2018-07-22 2025-12-23 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy for primary mitochondrial diseases
WO2020021535A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
CN115427052A (zh) * 2020-03-31 2022-12-02 米诺维亚治疗公司 线粒体加强疗法
MX2022012157A (es) * 2020-03-31 2023-02-15 Minovia Therapeutics Ltd Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas.
TWI780431B (zh) * 2020-05-08 2022-10-11 台灣粒線體應用技術股份有限公司 新穎性醫藥組合物及其於修復肝臟損傷、治療肝臟損傷相關疾病與提升肝臟功能之用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2688125A1 (en) * 2007-05-02 2008-11-13 The Mclean Hospital Corporation Methods and compositions for mitochondrial replacement therapy
IL282198B2 (en) * 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
WO2016008937A1 (en) * 2014-07-16 2016-01-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the intercellular transfer of isolated mitochondria in recipient cells
US20180030413A1 (en) * 2015-02-26 2018-02-01 Minovia Therapeutics Ltd. Mammalian cells enriched with functional mitochondria
US10537594B2 (en) * 2015-02-27 2020-01-21 University Of Connecticut Targeted transplantation of mitochondria to hepatocytes
WO2018088874A1 (ko) * 2016-11-14 2018-05-17 주식회사 파이안바이오테크놀로지 외래 미토콘드리아를 세포로 전달하는 방법
CN110022884A (zh) * 2016-11-30 2019-07-16 白雁生物技术公司 含有线粒体的药物组合物

Similar Documents

Publication Publication Date Title
Zhidu et al. Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities
JP2021532091A5 (cg-RX-API-DMAC10.html)
Han et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases
Li et al. Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
JP2021532094A5 (cg-RX-API-DMAC10.html)
Galderisi et al. Clinical trials based on mesenchymal stromal cells are exponentially increasing: where are we in recent years?
Xie et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
Zhao et al. Emerging role of mesenchymal stem cell-derived exosomes in regenerative medicine
Lee et al. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease
Sordi Mesenchymal stem cell homing capacity
Yagi et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing
Péault et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy
US20120201791A1 (en) Methods of treating diseases or conditions using mesenchymal stem cells
JP2022519409A5 (cg-RX-API-DMAC10.html)
JP2021531288A5 (cg-RX-API-DMAC10.html)
JP2021532093A5 (cg-RX-API-DMAC10.html)
RU2014108878A (ru) Лечение заболевания периферических сосудов при помощи клеток, полученных из ткани пуповины
JP2021512874A (ja) 単離ミトコンドリアを含む関節リウマチの予防または治療のための医薬組成物
JP2021532095A (ja) 肝臓疾患のミトコンドリア増強療法
JP2016138092A (ja) 肝疾患を治療するための間葉系幹細胞
US20170204151A1 (en) Mesenchymal Stem Cells Expressing Biomarkers that Predict the Effectiveness of Mesenchymal Stem Cells for Treating Diseases and Disorders
CN112143705B (zh) 一种双基因修饰的干细胞及其用途
TW202546218A (zh) 基因工程間質幹細胞及其用途
Eom et al. Mesenchymal stem cell therapy for liver disease: current status and future perspectives
JP2021531281A5 (cg-RX-API-DMAC10.html)